Verenium Achieves Financial Milestone in Research Collaboration with Syngenta
News Jan 10, 2008
Verenium Corporation has announced that it has achieved an important technical milestone associated with a research program with Syngenta AG. As a result of this achievement, Verenium will receive a $500,000 payment from Syngenta.
A core component of this research effort utilized Verenium’s DirectEvolution™ technology to engineer the properties of a key enzyme in the biosynthesis of starch.
“This milestone marks an important validation of Verenium’s evolution technologies in the advancement of high-value crop traits” said Carlos A. Riva, President and Chief Executive Officer at Verenium.
“This progress in the biosynthesis of starch brings the enormous potential of biofuels another step closer,” says Ray Riley, head of research and product development in corn and soybeans for Syngenta.
“Traits specifically designed to increase productivity of biofuels linked with Syngenta elite genetics and input traits that protect the crop’s yield potential are intended to bring increased productivity for growers and cost-effective sustainable production for biofuels manufacturers.”
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections. Now, a new machine learning technique will help predict the risk of developing a serious, and possibly life-threatening S. epidermidis infection.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019